Lupin wins U.S. FDA approval for 100 mg and 200 mg modafinil tablets

Verifying
  • Lupin received U.S. FDA approval for 100 mg and 200 mg modafinil tablets.
  • $70.7 million was the reference product’s estimated annual U.S. sales through July 2026.
  • Lupin’s tablets were approved as bioequivalent to Nuvo Pharmaceuticals’ Provigil Tablets.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.